Preclinical absorption, distribution, metabolism, excretion, and pharmacokinetic––pharmacodynamic modelling of N-(4-(3-((3S,4R)-1-ethyl-3-fluoropiperidine-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-4-yloxy)-3-fluorophenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide, a novel MET kinase inhibitor

By Liederer Bianca M.   Berezhkovskiy Leonid M.   Dean Brian J.   Dinkel Vikki   Peng Jing   Merchant Mark   Plise Emile G.   Wong Harvey   Liu Xingrong  

Xenobiotica, Vol. 41, Iss. 4, 2011-04 ,pp. : 327-339

Informa Healthcare

Access to resources Recommend Favorite

Docking Study of Ligands into the Colchicine Binding Site of Tubulin

By Farce Amaury   Loge Cedric   Gallet Sebastien   Lebegue Nicolas   Carato Pascal   Chavatte Philippe   Berthelot Pascal   Lesieur Daniel  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 19, Iss. 6, 2004-12 ,pp. : 541-547

Informa Healthcare

Access to resources Recommend Favorite

Chemopreventive potential of 3-[2,6-bis(4-fluorophenyl)-3-methylpiperidin-4-ylideneamino]-2-thioxoimidazolidin-4-one on 7,12-dimethylbenz[a]anthracene (DMBA) induced hamster buccal pouch carcinogenesis

By Thanusu J.   Kanagarajan V.   Nagini S.   Gopalakrishnan M.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 25, Iss. 6, 2010-12 ,pp. : 836-843

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of 3-(4′′-(4″″-fluorophenyl)-6′′-phenylpyrimidin-2′′-yl)-2-phenylthiazolidin-4-one for in vivo modulation of biomarkers of chemoprevention in the 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis

By Thanusu J.   Kanagarajan V.   Nagini S.   Gopalakrishnan M.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 26, Iss. 3, 2011-06 ,pp. : 422-429

Informa Healthcare

Access to resources Recommend Favorite

A Glycolytic Enzyme Binding Domain on Tubulin

By Volker K.W.   Knull H.R.  

Archives of Biochemistry and Biophysics, Vol. 338, Iss. 2, 1997-02 ,pp. : 237-243

Elsevier

Access to resources Recommend Favorite